Research programme: oral TGF-beta antagonists - Scios
Alternative Names: SD 093; SD 208 - Scios; Transforming growth factor-beta oral antagonists research programme - SciosLatest Information Update: 16 Jul 2016
At a glance
- Originator Scios
- Class Small molecules
- Mechanism of Action Transforming growth factor beta inhibitors; Transforming growth factor beta1 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer; Chronic obstructive pulmonary disease; Heart failure; Myocardial infarction; Pancreatic cancer
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Cancer in USA (PO)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Chronic-obstructive-pulmonary-disease in USA (PO)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Heart-failure in USA (PO)